Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Directorate Change

25 Jun 2019 07:00

RNS Number : 2533D
Renishaw PLC
25 June 2019
Β 

Renishaw plc (the "Company")

Β 

Β 

Directorate Change

Β 

The Company today announces that Geoff McFarland, Group Engineering Director, has informed the Board that, due to family reasons, he has decided to resign as a Director of the Board with effect from 30 June 2019.

Β 

The Company is pleased to announce that Geoff and the Board have agreed that he will continue to work with the Company in a new role as Director of Group Technology, reporting to Chief Executive, Will Lee, with responsibility for Renishaw's research centres and intellectual property. This role, while not full time, will allow the Company to continue to be able to draw on the benefits of Geoff's broad product and market expertise developed over 25 years with Renishaw.

Β 

Geoff joined Renishaw in 1994 and became the Director and General Manager of the CMM Products Division in 1999. He joined the Board in 2002. His current responsibilities are for Group Engineering, Group intellectual property and R&D. His previous responsibilities have included the additive manufacturing product line.

Β 

Sir David McMurtry, Executive Chairman, commented:

Β 

"We fully respect and support Geoff's decision which he has made for family reasons. On behalf of the Board I would like to thank Geoff for the invaluable contribution that he has already made to the developments that have helped Renishaw grow into the global technology leader that it is today. I look forward to continuing to work with Geoff in his new role."

Β 

Will Lee, Chief Executive, commented:

Β 

"I have worked with Geoff for many years, during which time he has been very supportive of me in my various roles in the business. While I am sorry that he is leaving the Board, I am very pleased that we will still benefit from his expertise and knowledge of the research community."

Β 

Notes

In accordance with Section 430(2B) of the Companies Act 2006, the Company confirms that no payment will be made to Geoff McFarland as result of his decision to step down from the Board.Β Geoff will continue to receive his normal salary and benefits for the period until 30 June, which will be in accordance with the Directors' Remuneration Policy approved by shareholders at the Company's AGM in October 2017.Β Part of Geoff's 2018 bonus was deferred for three years in the form of the grant of an award over 3,051 shares under the Renishaw plc Deferred Annual Equity Incentive Plan. This award will be released on the original timetable and remains subject to malus and clawback provisions.Β In his new position, from 1 July Geoff will receive remuneration that includes a base salary, discretionary bonus and other benefits that are appropriate to this role.

Β 

Β 

Mark Noble

General Counsel & Company Secretary

25 June 2019

Β 

Renishaw plc

Β 

Registered office:

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number:

01106260, England and Wales

LEI number:

21380048ADXM6Z67CT18

Telephone:

+44 (0)1453 524524

Website:

www.renishaw.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOAFIMFTMBBTBRL
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.